RxDoctor Payments Data

Troy Lamar, MD

Surgery · Arcadia, CANPI 1376629030

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $8,500 of the $10,730 with a category attached, or 79.2%. Intuitive Surgical accounts for 79.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $8,798 and has fallen 97.8% since, to $194 in 2025.

$10,730in general payments, 2019–2025

Across 71 payments — averaging $151.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$9K
  • Intra-sana Laboratories$645
  • Johnson & Johnson$563
  • Medtronic$360
  • Boston Scientific$234
  • Covidien LP$147
  • plus $214 from 5 others
$36,695in ownership & investment interests, 2019–2025

Across 2 payments — averaging $18,348 each. An ownership or investment interest held by the physician or an immediate family member.

  • Overture Orthopaedics$37K
  • Pristine Surgical LLC$0

What the payments were for

  • Speaking & faculty fees$8,50079%
  • Travel & lodging$4604%
  • Food & beverage$1,77016%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,730 in reported general payments places this provider in the 75th percentile of 2,363 surgery providers in California.

See all surgery providers in California →

Medicare billing

Part B allowed, 2024
$21,258
Medicare patients
69
Services billed
102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl74$216
Sucralfate15$215

Paid to pharmacies, not to this prescriber.

Other surgery in Arcadia

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →